Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on June 27th, 2018%
An international agricultural network is partnering with a private company to boost the group’s capabilities in satellite imaging, big data analytics, and artificial intelligence. . . . → Read More: Agriculture Group Adapts Satellite Imaging, A.I., Big Data
By Alan, on June 11th, 2018%
A single technology platform is being used to design and produce vaccines that in tests with lab animals protect against a number of infectious diseases. . . . → Read More: Single Technology Produces Vaccines for Multiple Infectious Diseases
By Alan, on March 29th, 2018% A clinical trial in Kenya shows blood from people who take a current anti-parasite drug can kill mosquitoes carrying malaria, offering a potential new strategy for controlling this disease. . . . → Read More: Drug Shown Able to Kill Malaria-Carrier Mosquitoes
By Alan, on April 24th, 2017% An experimental drug made from dried Artemisia annua plant leaves cured patients in Africa with malaria infections that became resistant to current drugs. . . . → Read More: Plant-Based Drug Shown to Cure Drug-Resistant Malaria
By Alan, on March 2nd, 2017% Two biotechnology companies are collaborating to discover new vaccines protecting against Ebola and Zika viruses that present global threats to public health. . . . → Read More: Biotech Companies to Discover Ebola, Zika Vaccines
By Alan, on January 18th, 2017% A group of 22 pharmaceutical companies is supporting worldwide projects to improve access to prevention and treatments for chronic disorders like cancer and heart disease, in lower-resource regions. . . . → Read More: Pharma Firms Start Non-Communicable Disease Initiative
By Alan, on August 31st, 2016% An experimental drug designed to treat solid tumor cancers was shown in lab tests to rid mice of human African trypanosomiasis, also known as sleeping sickness. . . . → Read More: Sleeping Sickness Treatment Found in Cancer Drug
By Alan, on July 15th, 2016% A new challenge seeks technologies and solutions to reduce child mortality and improve the health of children in low-resource regions of the world. . . . → Read More: $1 Million Challenge Seeks Child Health Solutions
By Alan, on May 19th, 2016% David Raiser, left, and Iain MacLeod, founders of Aldatu Biosciences (Aldatu Biosciences)
19 May 2016. A spin-off company from Harvard University is licensing genetics research to develop more powerful tools to detect drug-resistant strains of HIV. Financial details of the agreement between the 2 year-old Aldatu Biosciences Inc. and Harvard were not disclosed.
. . . → Read More: Start-Up Licenses Genetics Technology for HIV Diagnostics
By Alan, on April 12th, 2016% The Carter Center, founded by former U.S. president Jimmy Carter, has been instrumental in eradicating river blindness in Africa. (share.america.gov)
12 April 2016. PATH research institute and medical test developer Standard Diagnostics are making available tests for the tropical diseases onchocerciasis and lymphatic filariasis. The rapid, point-of-care tests are designed to help health . . . → Read More: Tropical Disease Diagnostics Now on Market
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|
You must be logged in to post a comment.